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Abstract
Background: Origin of human adult Leydig cells (ALCs) is not well understood. This 
might be partly due to limited data available on the identification and location of 
human precursor and stem Leydig cells (SLCs) which hampers the study on the de-
velopment of ALCs.
Objectives: The aim of the present study was to investigate whether described 
human (PDGFRα, NGFR) and rodent (NES, PDGFRα, THY1, NR2F2) SLC markers are 
expressed by a common cell population within human adult testicular interstitial cells 
in vivo and before and after in vitro propagation.
Materials and methods: Immunohistochemical analyses were used to identify locali-
zation of human adult testicular interstitial cells expressing described SLC markers. 
Next, interstitial cells were isolated and cultured. The percentage of cells express-
ing one or more SLC markers was determined before and after culture using flow 
cytometry.
Results: NR2F2 and PDGFRα were present in peritubular, perivascular, and Leydig 
cells, while THY1 was expressed in peritubular and perivascular cells. Although NES 
and NGFR were expressed in endothelial cells, co-localization with PDGFRα was 
found for both in vitro, although for NGFR only after culture. All marker positive cells 
were able to undergo propagation in vitro.
Discussion: The partly overlap in localization and overlap in expression in human tes-
ticular cells indicate that PDGFRα, NR2F2, and THY1 are expressed within the same 
ALC developmental lineage from SLCs. Based on the in vitro results, this is also true 
for NES and after in vitro propagation for NGFR.
Conclusion: Our results that earlier described SLC markers are expressed in overlap-
ping human interstitial cell population opens up further research strategies aiming 
for a better insight in the Leydig cell lineage and will be helpful for development of 
strategies to cure ALC dysfunction.
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1  | INTRODUC TION
Human stem Leydig cells (SLCs) might be an interesting cell popu-
lation for possible use in future cell therapy to restore testosterone 
levels in adult men with primary hypogonadism. Although the current 
therapy for hypogonadism, testosterone replacement therapy (TRT), 
is successful in restoring serum testosterone levels, bone density, 
and muscle mass, it increases risks of prostate cancer, cardiovascular 
disease, and infertility.1,2 Future SLC cell therapy to restore physio-
logical testosterone production in the testis will circumvent these 
adverse effects as well as the burden of lifelong TRT. To achieve this, 
proper identification of human adult SLCs is essential. Limited data 
are available on the identity and origin of these cells as well as there 
is uncertainty regarding the location of the SLCs in the adult human 
testis.
The development of human Leydig cells can be divided in three 
phases, based on morphological characteristics and a triphasic 
pattern in hormone release. The first Leydig cell population ap-
pears during fetal life and is responsible for the high testosterone 
production between 8 and 16 weeks of gestation.3 A second peak 
in testosterone levels, and concomitantly in Leydig cell number, 
is found during the neonatal period 2-3 months after birth.4-7 
Although during childhood a period of quiescence in steroidogen-
esis is seen, an infantile Leydig cell population is identified, which 
is thought to have developed from regressed neonatal Leydig cells 
(NNLC).4,8 Just before puberty, the hypothalamic-pituitary-testic-
ular axis is reactivated and adult Leydig cells (ALCs) develop that 
are responsible for the production of testosterone during puberty 
and adult life5 (reviewed in 9). These ALCs are thought to develop 
through differentiation of stem/precursor cells, and/or originate 
from regressed NNLCs and infantile Leydig cells.6,9
The majority of studies targeting the identification of SLCs in 
the adult testis have been performed in rodents. These studies 
show that SLCs in the rodent testis are mainly located in peritubular 
and perivascular regions.10-12 A number of studies in rodents have 
identified markers for SLCs such as platelet-derived growth factor 
receptor alpha (PDGFRα, also called CD140a),13-15 nestin (NES),16,17 
integrin subunit alpha V (ITGAV, also called CD51),16,18 nuclear re-
ceptor subfamily 2, group F, member 2 (NR2F2, also called COUP-
TFII),19 and Thy-1 cell surface antigen (THY1, also called CD90).20
Morphological changes during ALC development show simi-
larities in humans and rodents and in both, rodents and primates, 
this developmental process is dependent on LH (reviewed in21). 
However, there are also differences in Leydig cell development be-
tween rodent and human. In contrast to the triphasic development 
of the Leydig cell population in human, there is a biphasic pattern 
in Leydig cell development in rodent with fetal Leydig cells (FLCs) 
and ALCs. A neonatal Leydig cell population is lacking in rodents. In 
addition, whereas in human the development of the FLC population 
is dependent on hCG, this is not the case for rodent FLCs which de-
velop in the absence of functional luteinizing hormone chorionic go-
nadotropin receptors (LHCGRs).22,23
This raises the question if markers described for rodent SLCs are 
applicable for the identification and isolation of human SLCs from 
the adult testis. Using the rodent SLC marker PDGFRα, cells in the 
human testis located around the seminiferous tubules in the peritu-
bular cell layer were identified.24 These cells were able to differen-
tiate in vitro into cells with Leydig cell characteristics.24,25 Another 
SLC marker, nerve growth factor receptor (NGFR, also called CD271 
or p75) is expressed in NES+ cells in both a peritubular and vascular 
cell location in the adult human testis.26
Since several origins for ALCs are suggested in the adult human 
testis, namely undifferentiated multipotent stem cells, regressed 
NNLC, infantile LCs or regressed FLCs,6,9,27 it is interesting to in-
vestigate whether the SLC markers identify one or various SLC/
progenitor cell populations. Therefore, the aim of this study was 
to determine whether previously identified human and rodent SLC 
markers are expressed by a common cell population within the adult 
human testicular interstitium. We investigated in which cell popu-
lation the reported SLC markers are expressed in the interstitial 
compartment of the adult human testis. In addition, we investigated 
whether isolated interstitial cells (co-)express the SLC markers be-
fore and after in vitro propagation.
2  | MATERIAL S AND METHODS
2.1 | Human testicular tissue
Adult spare testicular tissue was obtained from 9 prostate cancer 
patients who had undergone bilateral orchiectomy. This surgery was 
part of their treatment procedure, and spare tissue was donated 
for research after informed consent. In accordance with Dutch law, 
spare tissues can be used for research with permission of the pa-
tients without further permission of an ethical committee since no 
additional interventions were needed to obtain these samples. In all 
cases, full spermatogenesis was confirmed by histological analysis. 
Immediately after receiving the tissue, part of the biopsies were fixed 
overnight in paraformaldehyde (4% (w/v) PFA (Merck, Germany) in 
phosphate-buffered saline (PBS, pH = 7.4)) or modified methacarn 
(88.8% (v/v) methanol (Merck Millipore, USA) + 11.2% (v/v) glacial 
acetic acid) fixatives, or first fixed for 6 hours in 4% phosphate-
buffered formaldehyde solution (Roti-Histofix, Carl Roth GmbH, 
Germany) followed by overnight fixation in diluted bouin (23.8% 
(v/v) 37% formaldehyde (Merck, Germany) + 71.4% (v/v) 0.9% picric 
acid (Sigma-Aldrich, USA) + 4.8% (v/v) glacial acid (Merck Millipore, 
USA)). The fixed biopsies were then dehydrated and embedded in 
paraffin and stored at 4°C for later use. In addition, remaining small 
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biopsy pieces of tissue were cryopreserved in Minimal Essential 
Medium (MEM, Gibco, Thermo Fisher Scientific, USA) supplemented 
with 20% fetal bovine serum (FBS, Gibco, Thermo Fisher Scientific, 
USA) and 8% dimethylsulfoxide (DMSO, EuroClone S.p.A., Italy) 
using a Coolcell freezing container (BioCision, USA) and stored at 
−196°C until cell isolation.
2.2 | Selection of markers for rodent SLCs
Five markers, namely NR2F2, PDGFRα, THY1, NES, and NGFR, were 
selected since these markers were proposed in the literature to iden-
tify SLCs in rodents and/or humans (Table 1). CD51 was excluded 
from this selection, because this marker was shown to be expressed 
by ALCs in the human testis and therefore not suitable for the iden-
tification of SLCs exclusively.26
2.3 | Immunohistochemical and 
immunofluorescence staining
For immunohistochemical and fluorescence staining, 5-µm par-
affin sections were used. Before staining, the sections were de-
paraffinized and rehydrated. When necessary, antigen retrieval 
was performed using a heat-induced method in a microwave for 
10 min in 0.01 M citrate buffer (pH = 6). To inactivate endogenous 
TA B L E  1   Overview of described markers identifying stem Leydig cells
Marker Studies Species Evidence that marker identifies stem cells
Described location in 
testis
NR2F2 Kilcoyne 
et al (2014)19
Fetal and 
adult rats
After EDS treatment, these cells start expressing 3β-HSD
Transgenic lineage tracing of NR2F2+ cells from fetal testis into ALCs 
in adult testis
Peritubular layer 
and other cells in 
interstitium
PDGFRα Ge 
et al (2006)15
Neonatal 
rats
In vitro differentiation into testosterone-producing cells, expressing 
Leydig cell markers
Cells express 3β-HSD after transplantation in testis of EDS-treated 
rats
Not described
Stanley 
et al (2012)13
EDS-
treated 
adult rats
In vitro differentiation into testosterone-producing cells
In vitro recovery of cell population and testosterone production after 
EDS treatment
Peritubular layer
Landreh 
et al (2013)14
Neonatal 
rats
Increase in steroidogenic gene expression and testosterone 
production after (Bu)2 cAMP stimulation in vitro
Peritubular layer
Landreh 
et al (2014)24
Adult 
human
Expression of pluripotent markers
Increase in steroidogenic gene expression and progesterone 
production after forskolin stimulation in vitro
Peritubular layer
Eliveld 
et al (2019)25
Adult 
human
Cells are able to differentiate into adipogenic, osteogenic, and 
chondrogenic lineage in vitro
Increase in steroidogenic gene expression and progesteron production 
after in vitro differentiation
Not described
THY1 Li et al (2016)20 Adult rats After culture of cells with LH and SAG, cells express 3β-HSD and 
produce testosterone
Peritubular layer
NES Davidoff 
et al (2004)17
Adult rats After EDS treatment, expression of NES in the testis increased
After EDS treatment, NES expressing cells become positive for 
CytP450
Vascular smooth 
muscle cells and 
pericytes
Jiang 
et al (2014)16
Nes-GFP 
transgenic 
mouse
Cells have self-renewal capacity and clonogenic potential in vitro
Cells are able to differentiate into neural, osteogenic, adipogenic, and 
chondrogenic lineage in vitro
After In vitro differentiation, cells produce testosterone and express 
Leydig cell markers
Peritubular layer 
and other cells in 
interstitium
NGFR Zhang 
et al (2017)26
Adult 
human
Cells have self-renewal capacity in vitro
Cells are able to differentiate into adipogenic, osteogenic, and 
chondrogenic lineage in vitro
Increase in steroidogenic gene expression and testosterone 
production after in vitro differentiation
Increase in serum testosterone levels after transplantation in testis of 
EDS-treated rats
Peritubular cells and 
blood vessels
Abbreviations: EDS, ethane dimethane sulfonate; 3β-HSD, 3-beta-hydroxysteroid dehydrogenase; ALC, Adult Leydig cell; (Bu)2cAMP, dibutyryl cyclic 
adenosine monophosphate; LH, Luteinizing hormone; SAG, Smoothened agonist; CytP450, Cytochrome P450 side chain cleavage enzyme; GFP, 
green fluorescent protein.
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peroxidase, a 10 min blocking step with 3% hydrogen peroxide 
(H2O2, Millipore, USA) in tris-buffered saline (TBS, pH = 7.6) was 
performed. Non-specific binding of the antibodies was blocked for 
1 hour at room temperature using superblock (ScyTek Laboratories, 
USA). Then, slides were incubated with the primary antibody diluted 
in bright diluent (Immunologic, The Netherlands) overnight at 4°C 
(for antibody details optimized for immune staining see Table S1). 
The second day, the sections were incubated with matched 
ready-to-use poly-HRP secondary antibody (Immunologic, The 
Netherlands) for 1 hour at room temperature. For visualization, 
DAB bright (Immunologic, The Netherlands) was used and coun-
terstaining was performed with hematoxylin. After dehydration, 
slides were covered with Entellan (Millipore, USA) and coverslips. 
TBS was used as a wash buffer. The staining was analyzed using 
an Olympus BX41 light microscope, and pictures were taken using 
the Leica Application Suite V4 program. For all antigens, immuno-
histochemical staining was performed on at least three biological 
replicates.
For double staining using immunofluorescence, autofluorescence 
was blocked with True black lipofuscin autofluorescence quencher 
(Biotium, USA). After overnight incubation with the primary antibody 
(Table S1), slides were incubated with 2 µg/ml secondary antibod-
ies goat-anti-mouse 488 or 555 and donkey-anti-rabbit 488 or 555 
(Invitrogen, Thermo Fisher Scientific, USA). Sections were analyzed 
using a Leica DM5000B fluorescence microscope, and pictures were 
taken using the Leica Application Suite Advanced Fluorescence pro-
gram. Double staining with DAB and Fast Red was performed using 
the Polink DS-MR-Hu D1 Kit (GBI Labs, USA) according to the pro-
tocol of the manufacturer.
Details regarding the primary and secondary antibodies and in-
cubation protocols used for immunohistochemistry and immunoflu-
orescence can be found in Table S1. All experiments were performed 
on at least three donors. Matched IgG isotypes were used as a neg-
ative control.
2.4 | Cell isolation and culture
The interstitial cell fraction (ICF) was isolated from cryopreserved-
thawed human testicular tissue fragments according to methods 
previously described.28,29 Briefly, a single enzymatic digestion step 
was used with 500 U/ml trypsin TRL3 (Worthington biochemical 
corporation, USA), 900 U/ml hyaluronidase type II (Sigma-Aldrich, 
USA), and 450 U/ml collagenase type I (Worthington Biochemical 
Corporation, USA). As a result, an enriched cell population contain-
ing interstitial cells, endothelial, perivascular, and peritubular cells will 
be present in the ICF cell isolate. For culture, cells were plated at a 
density of 4000 cells/cm2. Cells were cultured for a period of about 
3.5 to 4 weeks up to passage 3 or 4, respectively, using a propagation 
medium as described for rat SLCs with some modifications15: DMEM/
F12 with glutamax (Gibco, Thermo Fisher Scientific, USA) 2% FBS, 1% 
penicillin/streptomycin (pen/strep, Gibco, Thermo Fisher Scientific, 
USA), 1% Insulin/Transferrin/Sodium selenite (ITS, Gibco, Thermo 
Fisher Scientific, USA), 1nM dexamethasone (Sigma-Aldrich, USA), 
10 ng/ml platelet-derived growth factor-BB (PDGF-BB, Peprotech, 
USA), 10 ng/ml epidermal growth factor (EGF, Peprotech, USA), 5 ng/
ml human basic fibroblast growth factor (FGF2, Sigma-Aldrich, USA), 
and 1 ng/ml leukemia inhibitory factor (LIF, Prospec, Israel) at 37°C 
in a humidified 5% CO2 water-jacketed incubator. This medium was 
refreshed twice a week. The cells were passaged when a maximum 
of 80% confluence was reached by detaching the cells using accutase 
(Sigma-Aldrich, USA) after which the cells were plated again at a den-
sity of 4000 cells/cm2.
2.5 | Flow cytometry analysis
For the flow cytometry analyses on non-cultured cells, we let the 
cells recover after enzymatic cell isolation for 24 hours before con-
tinuing with the FACS procedure because the enzymes used for cell 
isolation affects the presence of the cell surface markers (data not 
shown). For FACS analyses on cultured cells, the cells directly after 
detaching with accutase at passage 3 or 4 were used. The cells were 
fixed in BD Cytofix/Cytoperm (BD biosciences, USA) after stain-
ing with the Zombie violet fixable viability kit (BioLegend, USA) 
to identify dead cells and select for viable cells during analyses. 
Fixed cells were stained with fluorochrome-conjugated antibodies 
to detect the presence of the various SLC markers. We titrated all 
antibodies first to determine the correct antibody concentration 
for FACS analyses. Details of the used antibodies for FACS analy-
ses are described in Table S2. FACS analyses were performed on 
the BD FACSCanto II Flowcytometer or the BD LSRFortessa cell 
analyzer flow cytometer. FlowJo 10.2 software was used to analyze 
the data and GraphPad Prism 5 program to make the graphs. All 
experiments were reproduced on at least three donors. Matched 
isotype controls were used to determine background fluorescence. 
The flow cytometry data were expressed as the mean percentage 
of positive cells ± SEM.
3  | RESULTS
3.1 | Localization of putative SLC markers in the 
adult human testis
NR2F2 immunostaining was detected in peritubular cells, perivascu-
lar cells, and in Leydig cells (Figure 1). Co-localization of NR2F2 with 
Cytochrome P450 Family 17, Subfamily A, Member 1 (CYP17A1), a 
specific marker for Leydig cells, confirmed that human Leydig cells 
express NR2F2 (Figure S1). Cells positive for THY1 were found sur-
rounding the seminiferous tubules and the blood vessels. THY1 im-
munostaining was not observed in Leydig cells (Figure 1). Expression 
of NES in the adult human testis was limited to the endothelial cells 
of the blood vessels (Figure 1).
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3.2 | In vitro propagation of the human interstitial 
cell fraction containing cells with putative 
SLC markers
The isolated, uncultured, interstitial cell fraction (ICF) included 
cells that were positive for the markers NR2F2 (6 ± 2.5%), THY1 
(17 ± 5.4%), and NES (6 ± 1.7%) (Figure 2A and C). After 23-25 days 
of culture, ICF cell number increased 100- to 400-fold with a high 
variability per cell culture and per patient. Within this increased 
cell population, the percentage of the cells positive for SLC markers 
increased to 89% (±5.2), 100% (±0.05), and 54% (±5.9) for NR2F2, 
THY1, and NES, respectively (Figure 2B and C).
3.3 | Putative SLC marker expression in relation 
to the reported human SLC marker PDGFRα
PDGFRα immunostaining was, like NR2F2, found in both peritu-
bular and perivascular cells, as well as in Leydig cells (Figure 3A). 
The isolated uncultured ICF cells consisted of 15% (±3.4) PDGFRα+ 
cells (Figure 3B and C). Within this PDGFRα+ cell population, the 
majority of the cells were positive for THY1 and around half of the 
PDGFRα+ cells expressed NES (Figure 3C). Due to high cell loss dur-
ing staining of the intranuclear cell marker NR2F2 for FACS analy-
ses, we could not collect sufficient cell numbers of the uncultured 
cell fraction to analyze NR2F2 expression within the PDGFRα+ cell 
population. Since we were also not able to obtain reliable results 
for co-localization of NR2F2 with PDGFRα by immunofluorescence 
staining on sections of fixed testes, we studied the co-expression 
of NR2F2 and PDGFRα on propagated ICF cells using FACS. After 
3 weeks of culture, 96% (± 2.3) of the ICF cells were positive for 
PDGFRα+ (Figure 3B and D). Almost all PDGFRα+ cells expressed 
NR2F2 and THY1, while about half of the PDGFRα+ cells expressed 
NES (Figure 3D), indicating that the percentages of at least the 
THY1+ and NES+ populations within the PDGFRα+ population re-
main constant during culture. There were THY1+/PDGFRα- and 
NES+/PDGFRα− cells present both immediately after isolation and 
following culture (Figure S2).
F I G U R E  1   Location of rodent stem 
Leydig cell markers in human testicular 
tissue. Representative pictures of the 
immunohistochemical staining. Left 
column is showing an overview of the 
immunohistochemical staining in the 
testis, and middle columns in higher 
magnifications are showing blood vessels, 
cells of the peritubular myoid cell layer 
and Leydig cells, respectively. In the right 
column, the IgG control is shown. Scale 
bar is 20 µm
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3.4 | Putative SLC marker expression in relation 
to the reported human SLC marker NGFR
Immunohistochemical staining revealed expression of NGFR in the 
endothelial cells (Figure 4A). Co-localization with an endothelial 
marker CD31 confirmed localization of NGFR in the endothelial cell 
layer (Figure S3). Co-localization of NGFR with NES was confirmed 
(Figure 4B). No co-localization was found for NGFR (arrowhead) with 
the perivascular expression of NR2F2 (arrow) (Figure 4C) and NGFR 
with THY1 (Figure 4D). Immediately after isolation, a low percentage 
of cells expressing NGFR could be identified (3 ± 1.3%) within the ICF 
(Figure 4E and G). After propagation of the ICF cells, the NGFR+ cells 
were present in a lower percentage (1 ± 0.5%) (Figure 4F-G). Since the 
total ICF increased 100- to 400-fold in cell number, this indicates an 
increase in number of NGFR+ cells by 30- to 130-fold during 3.5 weeks 
of culture. Hardly any of the NGFR+ cells co-expressed PDGFRα im-
mediately after isolation (Figure 4E), but after culture a clear NGFR+/
PDGFRα+ cell population could be identified (Figure 4F).
4  | DISCUSSION
All investigated markers were detected in cells located in or around 
the blood vessels in adult human testicular tissue. While expression 
of NES and NGFR seemed to be limited to the vascular endothe-
lial cells, NR2F2, PDGFRα, and THY1 were expressed in the outer 
perivascular layer of the blood vessels. NR2F2, PDGFRα, and THY1 
were also expressed in the peritubular cells, while on top of that 
F I G U R E  2   In vitro propagation of 
human interstitial cells expressing putative 
stem Leydig cell markers NR2F2, THY1, 
or NES. Representative fluorescence-
activated cell sorting (FACS) analyses of 
the markers on isolated primary interstitial 
cells before (A) and after culture (B). (C) 
Percentage of cells within the interstitial 
cell fraction (ICF) expressing the indicated 
markers before (n = 3) and after culture 
(n = 4). Before culture, the percentage 
of cells expressing each marker was 
below 25%, while after culture almost 
all cells expressed NR2F2 and THY1 and 
around half of the cells were positive 
for NES. Data are represented as mean 
percentage ± SEM
ICF cells after isolation Cultured ICF cells
Positive cells (%) Positive cells (%)
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F I G U R E  3   Rodent stem Leydig cell markers in relation to PDGFRα in human testis. The expression of PDGFRα was determined in human 
testicular tissue and cells. (A) Representative pictures of the immunohistochemical staining of PDGFRα on perivascular, peritubular and 
adult Leydig cells in human adult testis. (B) Percentage of PDGFRα+ cells within the interstitial cell fraction before (n = 3) and after culture 
(n = 4). Representative FACS plots of uncultured (C) and cultured (D) ICF cells. Directly after isolation, almost all PDGFRα+ cells co-expressed 
also THY1 (89%), while NES is co-expressed in around 60% of the PDGFRα+ cells. After 3.5 weeks of culture, almost all PDGFRα+ cells co-
expressed NR2F2 and THY1 (98% and 99%, respectively), and half of the PDGFRα+ cells co-expressed NES. Scale bar is 20 µm. Data are 
represented as mean percentage ± SEM
(A)
(B)
(C) (D)
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F I G U R E  4   Rodent stem Leydig cell markers in relation to NGFR in human testis. The expression of NGFR was investigated in human 
testicular tissue, in isolated and cultured cells. (A) NGFR expression was limited in cells of the inner layer of the blood vessels. (B) These 
NGFR+ cells of the inner layer of the blood vessels were co-localizing NES. NR2F2 and THY1 are expressed by outer cell layers of the 
blood vessels, and no co-localization was found with NGFR in sections of the human testis (C and D). (E) Representative FACS analyses of 
interstitial cells after isolation. The small percentage of NGFR-positive cells was negative for PDGFRα. (F) Representative FACS analyses 
of interstitial cells after culture. Still a small percentage of NGFR+ cells could be found, of which the majority co-expressed PDGFRα. (G) 
Average of percentage of NGFR-positive cells of uncultured (3 ± 1.3%) and cultured cell population (1 ± 0.5%) (n = 3). Scale bar is 20 µm. 
Data are represented as mean percentage ± SEM
(A)
(C)
(E) (F) (G)
(D)
(B)
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NR2F2 and PDGFRα were also detected in ALCs. In addition to the 
expression of these putative SLC markers in interstitial cells in vivo, 
we were able to identify cells expressing these markers in isolated 
and in vitro propagated ICF cells. After this phase of proliferation, al-
most all cells expressed PDGFRα, NR2F2, and THY1 and around half 
of these cells expressed NES. Only a small proportion of these cells 
expressed NGFR. The interstitial localization and (partly) co-expres-
sion patterns in vitro of the various SLC markers suggest that these 
markers identify partly a common cell population of interstitial cells.
The strength of the present study is that we, to our knowledge, 
for the first time simultaneously investigated the expression of sev-
eral putative SLC markers in human testicular tissue both in vivo and 
in vitro. This combination allows us to investigate co-localization and 
co-expression of these SLC markers.
A limitation of the present study is that due to the low number 
of cells in the isolated ICF fractions we were not able to investigate 
the differentiation potential of the various cell populations positive 
for these markers into functional Leydig cells. We and others have 
previously shown that propagated human testicular PDGFRα+ and 
NGFR+ cells are able to differentiate into cells with Leydig cell char-
acteristics.24-26 Therefore, we focussed in the present study on the 
co-localization of these markers with other SLC markers.
To our knowledge, our results show for the first time, the lo-
calization of NR2F2 in adult human testis. Peritubular cells, peri-
vascular cells, and ALCs express NR2F2. For PDGFRα, of which 
the expression was observed at the same locations as NR2F2, 
our results differ partly from other studies where PDGFRα ex-
pression in the adult human testis is described for peritubular 
cells,24,30 spermatids,24 or Sertoli and Leydig cells.31 This suggests 
that PDGFRα immunostaining in the human testis is highly vari-
able, presumably depending on the antibody source and staining 
protocol used. Our present immunohistochemical staining pat-
tern of PDGFRα was confirmed by our FACS analyses identifying 
co-expression of PDGFRα and NR2F2 in almost 100% of cultured 
ICF cells, while in this analysis a different antibody was used for 
PDGFRα because of the suitability for FACS. The current study 
further shows that THY1, one of the markers to identify MSCs 
according to the minimal criteria,32 is expressed by peritubular 
cells and perivascular cells in the adult human testis, and not by 
ALCs. This is in line with studies on human peritubular cells where 
expression of THY1 was found.30,33 The co-expression of PDGFRα 
and THY1 immediately after isolation and following propagation 
of the cells in vitro confirmed the immunohistochemical localiza-
tion results that the THY1+ cells might be a subpopulation of the 
PDGFRα+ cells. Furthermore, since after culture almost 100% of 
the cells were positive for NR2F2, PDGFRα, and THY1, the cur-
rent culture conditions are suitable for the propagation of this 
NR2F2+/PDGFRα+/THY1+ cell population.
Based on the presence of NR2F2 and PDGFRα in ALCs, these 
markers are not suitable to identify solely SLCs in the human testis. 
THY1 might therefore be a more specific marker for enrichment of 
human SLCs since the expression is limited to perivascular and per-
itubular cells, regions described as SLC niche.10-12,20,34 A common 
progenitor for ALCs and myoid cells has been suggested before pu-
berty explaining the possible close relation of SLCs to myoid cells.35
Our finding that in the adult human testis the expression of the 
previously described SLC markers NES and NGFR is limited to the 
endothelial cells is unexpected as endothelial cells are committed 
differentiated cells in the inner wall of blood vessels. This suggests 
NES and NGFR might not be expressed by human SLCs and are 
expressed by a distinct cell population compared to the NR2F2+/
PDGFRα+/THY1+ cell population. This is different from previous 
studies where expression of NES in the human testis has been de-
scribed for peritubular cells and Leydig cells in addition to endothe-
lial cells,36 or be present in peritubular and vascular cells together 
with NGFR (Zhang et al, 2017). A possible explanation is that the 
expression in peritubular and Leydig cells of NES and NGFR may be 
very low and therefore difficult to detect by immunohistochemistry. 
Another explanation for the discrepancy in NES staining may be dif-
ferences in antibody source and staining protocols.
Our in vitro observations showed that ICF contained NES+/
PDGFRα+ cells showing a common cell population of these two 
markers that might contain SLCs. Since we already find this NES+/
PDGFRα+ population in ICF cells before culture, this implies there 
is a NES+/PDGFRα+ cell population present in the testicular tissue, 
which we were not able to detect by immunohistochemistry. Half of 
the NR2F2+/PDGFRα+/THY1+ cell population expressed NES. This 
subpopulation might be interesting in the enrichment of SLCs.
We did not detect a NGFR+/PDGFRα+ cell population before cul-
ture. Whether NGFR might also select for at least a subpopulation 
of SLCs in parallel to endothelial cells in vivo could not be confirmed 
by immunohistochemistry and FACS in the present study. In contrast 
to ICF cells immediately after isolation, we did observe a NGFR+/
PDGFRα+ cell population following propagation of the isolated ICF 
cells, similar to what has been described by Zhang and colleagues 
for cultured NGFR+ spheres.26 Furthermore, in that study it was 
shown that NGFR+ cells isolated from adult human testis can differ-
entiate in vitro into testosterone-producing cells. The appearance of 
this NGFR+/PDGFRα+ cell population in vitro in our study could be 
explained by a low undetectable expression of NGFR immediately 
after isolation that increases during culture. Another explanation 
might be that, although we tried to avoid this as much as possible, 
the enzymes used in the isolation protocol might have caused dam-
age to some membrane markers and not intracellular markers. This 
might explain the discrepancy in expression of NES (intracellular 
marker) and NGFR (membrane marker) immediately after cell isola-
tion. Another possibility is that NGFR+/PDGFRα+ cells might appear 
during culture due to the phenomenon of endothelial to mesenchy-
mal transition (EndMT). This is an important developmental mecha-
nism where endothelial cells transdifferentiate into MSCs in various 
tissues, (reviewed in37), including the testis,38-40 but can also occur in 
endothelial cells in vitro.41 Whether EndMT also plays a role in Leydig 
cell development in vitro and/or in vivo needs further investigation.
We investigated the propagation potential of the ICF cells in 
vitro, as this will be pivotal to obtain enough cells to allow further 
analyses on the characteristics and functional properties of the cells. 
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The presence of proliferative activity is one of the hallmarks of stem 
cells, indicating that the current cell culture condition stimulates 
proliferation of interstitial cells, including putative SLCs. The total 
ICF cells increased 100- to 400-fold in cell number in vitro. Since 
we cultured a mixed cell population of testicular ICF cells, we cannot 
rule out that the increase in number of cells expressing SLC mark-
ers could be due to cells that gain putative SLC marker expression 
during culture rather than propagation of a cell population express-
ing the SLC markers from the start of the culture. This should be kept 
in mind when further investigating these putative human cultured 
SLCs in more detail.
Based on our results, we show the studied markers are expressed 
within the same LC developmental lineage. Our results cannot assign 
the markers to any of the specific lineage of stem Leydig cells, re-
gressed NNLCs, infantile LCs or regressed FLCs. When interpreting 
the results, we propose a model for human ALC development based 
on localization in vivo and co-expression before and after culture 
of the investigated markers. When using the ALC developmental 
scheme as introduced by Prince5 and extended by Svechnikov et al,42 
we hypothesize that the markers PDGFRα, NR2F2, and THY1 belong 
to the developmental lineage of SLCs to ALCs since all three mark-
ers are detected in perivascular and peritubular cells, the previously 
identified SLC niche. Since THY1 is not expressed by ALCs, in con-
trast to PDGFRα and NR2F2, THY1+ cells are presumably less dif-
ferentiated in the direction of ALCs (Figure 5). Although SLCs might 
be present within the PDGFRα+/NR2F2+/THY1+ cell population, 
none of these markers identifies exclusively SLCs. Although the im-
muno-localization of NES and NGFR within endothelial cells would 
suggest no involvement in human ALC development, the presence 
of NES+/PDGFRα+ cells before and after culture indicates part of the 
NES expressing cells also belong to the same cell lineage as PDGFRα, 
NR2F2, and THY1 expressing cells. These cells might represent a cell 
type earlier in the process toward ALC development since it is a sub-
population of the PDGFRα+ cells (Figure 5). The in vitro expression 
after culture of NGFR+/PDGFRα+ in a small cell population in the 
current study and differentiation potential toward ALC of NGFR+ 
human testicular cells in previous study26 might imply involvement 
of NGFR in human ALC development as well.
Identification of human SLCs is an important step in the devel-
opment of possible future cell therapies for Leydig cell dysfunction. 
F I G U R E  5   Proposed scheme on 
the development of the human SLC 
toward ALC. Proposed scheme of human 
SLC marker expression during ALC 
development based on the data from 
the current study. Upper part shows 
the localization of cells expressing 
the markers within the adult testis by 
immunohistochemistry. The bars in 
the lower part show the expression 
patterns of the SLC markers within the 
human ALC development based on 
immunohistochemistry and FACS co-
expression. LC, Leydig cell
PDGFRα+
NR2F2+
THY1+
Seminiferous tubuleBlood vessel
PDGFRα+
NR2F2+
THY1+
NES+
NGFR+
Stem LC Immature LC Adult LC
PDGFRα+
NR2F2+
NR2F2
PDGFRα
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     |  11ELIVELD Et aL.
In the present study, expression of several putative SLC markers is 
evaluated in human testicular tissue and in isolated and cultured ICF 
cells. The combined study of the putative SLC markers allowed us 
to investigate co-localization and co-expression and showed that 
the putative markers overlap at least partly. Although these mark-
ers might be useful in the enrichment of human SLCs, none of these 
markers seemed to be expressed in one specific cell type in vivo. 
Our results and proposed hypothesis of Leydig cell development in 
humans opens up further research strategies aiming for a better in-
sight in the development of Leydig cells and toward novel therapies 
to rescue Leydig cell dysfunction.
5  | CONCLUSION
We show, based on in vivo locations and co-expression in vitro, that 
NR2F2, PDGFRα, and THY1 are located in the perivascular and peri-
tubular compartment and are expressed within the same ALC devel-
opmental lineage, containing SLCs. Cells expressing NES and NGFR 
are mostly located within the blood vessels, but based on partly 
overlap with the PDGFRα+ population in vitro, we hypothesized that 
these cells represent a subpopulation of NR2F2+/PDGFRα+/THY1+ 
cells in an early phase in the same LC development lineage.
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